Paxton Bach MD, MSc, ABIM, FRCPC, is a post-doctoral research fellow with the BC Centre on Substance Use and a Clinical Assistant Professor in the Department of Medicine at the University of British Columbia. He additionally serves as the Associate Director for the BCCSU Clinical Addiction Medicine Fellowship Program, and works as an addiction medicine physician and preceptor at St. Paul’s Hospital.
Dr. Bach conducts research in the area of opioid and stimulant use disorders, with a focus on epidemiologic trends in use and on the development of evidence-based treatment strategies. He is additionally interested in the management of complex medical co-morbidities in patients with concurrent substance use disorders, and exploring innovative ways to improve the care of this vulnerable population. Dr. Bach is currently a study physician for the OPTIMA trial, and is an interim co-investigator on the pRESTO trial. He is also a clinical mentor for the Canada Addiction Medicine Research Fellowship, and contributes to a variety of other educational programs and activities at the BCCSU.
Dr. Bach has received numerous awards and recognitions for his work, including participation in the NIDA funded Research in Addiction Medicine Scholars program, operated jointly through Boston University and the Yale School of Medicine. He has completed a Master’s degree in Experimental Medicine as well as fellowships in both General Internal Medicine and Addiction Medicine at UBC, and is certified as an addiction medicine specialist through the International Society of Addiction Medicine and the American Board of Preventative Medicine.